1/2

Trusted Supplier

FIEO Registered Export Ready

Liposome Di-adjuvant E

Name: Liposome Di-adjuvant E
SKU: 8618797
Availability: InStoreOnly

Sold by Swasti Exports · Manufacturer, Trader, Exporter, Importer · Vadodara, Gujarat, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

United States Minor Outlying Islands flag

Values shown are for Swasti Exports.

Compliance & Certifications

IEC Certificate

Suitable for

Importers · Distributors · Wholesalers

Vadodara Dispatch on request FIEO member

Swasti Exports

Manufacturer, Trader, Exporter, Importer · Vadodara, Gujarat, India

We are Merchant Exporter and supplying Chemicals, Agriculture products, Rices, spices, Kashmiri Saffron, Iranian saffron, Dates and so many products.

Registered address: Vadodara, India. Industry: Chemicals, Dyes & Paints > Chemical Industry Related Services.

View profile All products

Established

2020

Employees

1–10

GST

24AIXPB0733C1ZO

IEC code

AIXPB0733C

Export markets

GlobalLinker Member Since

Jul 2020

Turnover

100000 - 2500000.

Incorporation Type

On request

IEC Certificate FIEO

Product details

What are the specifications of this product?

Overview

Cholesterol and Phospholipid based bilayer liposomes; QS-21/3D-MPLA each at 50 µg/ml.

Product Description

RSV vaccine / Malaria vaccine / Adult tuberculosis vaccine, etc.Quality level: Research grade / GMP grade_x000D_

Description provided by Swasti Exports.

Specifications

Product Name	Liposome Di-adjuvant E
Composition	Cholesterol and phospholipid based bilayer liposomes
Adjuvant Components	QS-21 and 3D-MPLA
Component Concentration	Each at 50 µg/ml
Application	Vaccine research and formulation
Target Use Cases	RSV vaccine, malaria vaccine, adult tuberculosis vaccine
Quality Level	Research grade / GMP grade
Product Form	Liposome-based adjuvant formulation
Store Name	Swasti Exports
MOQ	1

Use cases

Category	Vaccine Adjuvants > Liposomal Adjuvants > QS-21/MPLA Liposome Adjuvant
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Liposome Di-adjuvant E. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the composition of Liposome Di-adjuvant E?

A: It is a cholesterol and phospholipid based bilayer liposome formulation containing QS-21 and 3D-MPLA, each at 50 µg/ml.

Q: Which vaccine development programs is this adjuvant most relevant for?

A: It is specifically relevant for RSV vaccine, malaria vaccine, and adult tuberculosis vaccine research and development.

Q: What quality grades are available for this product?

A: The product is offered in research grade and GMP grade versions.

Q: Why is the liposome format important for this adjuvant?

A: The liposomal bilayer format helps present the adjuvant components in a controlled formulation suited to advanced vaccine research and development.

Q: Is Liposome Di-adjuvant E suitable for GMP-related workflows?

A: Yes, the product listing specifies GMP grade availability, making it relevant for regulated formulation and development workflows.

Q: What makes this product different from a general adjuvant reagent?

A: It is a defined liposome-based adjuvant system with specific components and concentrations, intended for targeted vaccine research rather than general laboratory use.

Question not answered? Ask sellers directly — typical response within 4 hours.